Publications Office of the EU
LP s obsahem daratumumabu 2025 - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

LP s obsahem daratumumabu 2025

  • Published
    17/04/2025
  • Deadline
    21/05/2025
  • Awarded
    03/07/2025
  • Today
    15/05/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Fakultní nemocnice Olomouc
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ071 Olomoucký kraj
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
209,297,870.00 CZK
Tender reference number
Not available
Description

Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků splňujících požadavky SÚKL s obsahem účinné látky daratumumab.

Submission Method
Electronic via:
https://www.egordion.cz/nabidkaGORDION/profil/fnol
Tenders may be submitted
Electronic submission: required
https://www.egordion.cz/nabidkaGORDION/profil/fnol
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Celková nejnižší nabídková cena v Kč bez DPH
Estimated value
Not available
Final contracted value
209,297,870.00 CZK
Award of contract
Official name: Janssen-Cilag s.r.o.
Postal address:
Town: Praha - Jinonice
Postal code: 15800
Country:
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.